✦ LIBER ✦

Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans

✍ Scribed by Jiana Yuan; Michael Y. Tsai; Janet Hegland; Donald B. Hunninghake

Book ID: 118896514
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 931 KB
Volume: 87
Category: Article
ISSN: 0021-9150
DOI: 10.1016/0021-9150(91)90017-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Protective effect of fluvastatin sodium

Protective effect of fluvastatin sodium (XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro

✍ Kuniharu Suzumura; Mikiko Yasuhara; Keiko Tanaka; Toshikazu Suzuki 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 336 KB

Fluvastatin (Sandoz compound XU 62-320-

Fluvastatin (Sandoz compound XU 62-320- lescol), an HMG-CoA reductase inhibitor, in treatment of patients with type II a hyperlipidemia — Its efficacy and safety

✍ S. Rywik; U. Klosiewicz-Latoszek; G. Broda; W.B. Szostak 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Effect of fluvastatin sodium (XU62-320),

Effect of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on the induction of low-density lipoprotein receptor in HepG2 cells

✍ Kozo Hayashi; Jun-ichi Kurokawa; Shuichi Nomura; Yoshio Kuga; Yoshifumi Ohkura; 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 384 KB

Effects of HMG CoA reductase inhibitor o

Effects of HMG CoA reductase inhibitor on cholesterol absorption in obesity: Implications for the regulation of very-low-density lipoprotein B-100 metabolism

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Lipid-lowering response of the HMG-CoA r

Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in Brazilian patients with primary hypercholesterolemia

✍ Luis A. Salazar; Mario H. Hirata; Éder C.R. Quintão; Rosario D.C. Hirata 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

Although the efficacy of fluvastatin (HMG-CoA reductase inhibitor) in the treatment of primary hypercholesterolemia is well documented, a wide interindividual variation treatment response has been observed. We have studied the possible role of the AvaII (exon 13), HincII (exon 12), and PvuII (intron

Effects of CS-514 (eptastatin), an inhib

Effects of CS-514 (eptastatin), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, on serum lipid and apolipoprotein levels in heterozygous familial hypercholesterolemic patients treated by low density lipoprotein (LDL) -apheresis

✍ Hiroshi Mabuchi; Hajime Fujita; Ichiro Michishita; Mitsuaki Takeda; Kouji Kajina 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 456 KB